Broad view of heart shows otherwise missed pathology
Almost a quarter of all patients in a recent study who underwent CT angiography had findings outside the heart and great vessels, leading to several serious diagnoses being missed.
Almost a quarter of all patients in a recent study who underwent CT angiography had findings outside the heart and great vessels, leading to several serious diagnoses being missed. A broad viewing approach led to more workup and follow-up imaging.
Out of 6920 patients, 1642 had one or more extracardiac findings for a total of 1901 findings in the broad viewing scheme. Of all the patients, 16.2% had a finding necessitating therapy, workup, or follow-up. By engaging in just the focused viewing scheme, most therapy (90.9%), workup (64.1%), and follow-up (51.2%) needs were missed (AJR 2010;195:143-148).
Use of the focused approach resulted in fewer false-positive diagnoses, but five malignant tumors of the breast, 88 lung infiltrates, 43 cases of adenopathy, two cases of polycystic kidney disease, one breast abscess, and one case of splenic flexure diverticulitis were missed.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
